▲ Peaking
Health
CRISPR makes prostate cancer vulnerable to immunotherapy
Researchers are using CRISPR gene editing to make 'immune-cold' prostate tumors visible to immunotherapy, potentially overcoming cancer's stealth mechanisms.
Crispr
3 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Health
🔮 fades
DNA editing of human embryos reignites debate over designer babies
The identification of a master gene governing early human development is colliding with advancements in CRISPR precision, sparking new ethical debates.
◼ Archived
Health
🔮 fades
CRISPR enzyme precisely detects and shreds DNA in cancer mutations once considered 'undruggable'
CRISPR now targets 'undruggable' cancer mutations with surgical precision—could this rewrite oncology?